SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-11-001567
Filing Date
2011-03-30
Accepted
2011-03-29 19:04:18
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2010_soligenix.htm 10-K 1250806
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - EISNERAMPER LLP f10k2010ex23i_soligenix.htm EX-23.1 5431
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - AMPER, POLITZINER & M f10k2010ex23ii_soligenix.htm EX-23.2 3491
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) f10k2010ex31i_soligenix.htm EX-31.1 15757
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) f10k2010ex31ii_soligenix.htm EX-31.2 15380
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS f10k2010ex32i_soligenix.htm EX-32.1 7091
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS f10k2010ex32ii_soligenix.htm EX-32.2 7410
  Complete submission text file 0001213900-11-001567.txt   1306654
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16929 | Film No.: 11720084
SIC: 2834 Pharmaceutical Preparations